Ruhnke M, Schmidt-Westhausen A, Morschhäuser J
Universitätsklinikum Charité Campus Virchow Klinikum, Abteilung für Innere Medizin, Humboldt Universität zu Berlin, D-13353 Berlin, Germany.
J Antimicrob Chemother. 2000 Aug;46(2):291-5. doi: 10.1093/jac/46.2.291.
In this report, we describe a patient with recurrent episodes of oral candidosis who finally suffered from fluconazole-refractory oral and oesophageal candidosis. The patient was monitored for 4 years until his death from AIDS. During the observation period, persistent colonization with both Candida albicans and Candida dubliniensis was observed. From the appearance of the first episode of oral candidosis, the patient was treated with fluconazole for 18 months. The infection became unresponsive to fluconazole 400 mg/day. In vitro susceptibility testing revealed the development of resistance to fluconazole in C. albicans and C. dubliniensis. Molecular typing confirmed the persistence of the same C. albicans and C. dubliniensis strains which developed resistance after up to 3 years of asymptomatic colonization. This observation demonstrates that Candida spp. other than C. albicans may develop resistance to fluconazole in a patient who is repeatedly exposed to the drug.
在本报告中,我们描述了一名复发性口腔念珠菌病患者,该患者最终患上了对氟康唑耐药的口腔和食管念珠菌病。对该患者进行了4年的监测,直至其死于艾滋病。在观察期内,发现该患者持续感染白色念珠菌和都柏林念珠菌。从首次出现口腔念珠菌病发作起,该患者接受了18个月的氟康唑治疗。感染对每日400毫克氟康唑不再有反应。体外药敏试验显示白色念珠菌和都柏林念珠菌对氟康唑产生了耐药性。分子分型证实,在长达3年的无症状定植后产生耐药性的同一株白色念珠菌和都柏林念珠菌持续存在。这一观察结果表明,在反复接触该药物的患者中,除白色念珠菌外的其他念珠菌属可能会对氟康唑产生耐药性。